摘要
目的:探讨散光矫正型植入性眼内接触镜(TICL)矫治高度近视并散光的安全性、有效性、稳定性。方法:高度近视并散光的患者15例30眼接受散光矫正型眼内接触镜植入术,观察术后1,3,6,12mo时裸眼视力、矫正远视力、屈光状态、眼压、角膜内皮细胞计数及并发症情况等。结果:术后裸眼视力均有明显提高,术后12mo裸眼视力达到1.0以上的有27眼(90%),等效球镜±0.5D以内28眼(93%)。术后无1例矫正远视力下降1行或1行以上。术后1mo与术后12mo相比,30眼(100%)等效球镜变化均在0.5D之内。手术前后角膜内皮细胞计数比较无显著性差异(P=0.31)。术后12mo未见并发性白内障、继发性青光眼等并发症。结论:散光矫正型植入性眼内接触镜(TICL)矫治高度近视并散光安全、有效。
AIM： To evaluate the efficacy, safety and stability of toric implantable collamer lens （TICL） for patients with high myopic astigmatism. METHODS： Totally 15 patients （30 eyes） undergoing TICL placement were included. The uncorrected visual acuity （ UCVA ）, corrected distance visual acuity （ CDVA）, refraction,intraocular pressure, endothelial cell counts and complications were regularly observed on 1 month, 3, 6 and 12 months post-operation. RESULTS： All eyes had a significant increase in UCVA. 12 months after surgery, 27 eyes （90%） achieved UCVA better than 1. 0. 28 eyes （93% had a spherical equivalent （SE） within ＋_0.5D. None lost one or more lines of CDVA. 30 eyes changed within ＋ 0. 5D when comparing 1 month and 12 months. Postoperative endothelial cell density did not show a significant difference from preoperative measurements （ P= 0.31 ）. Complications were not found after surgery. CONCLUSION： TICL appears to be safe and effective for correction of high myopic astigmatism.
出处
《国际眼科杂志》
CAS
2013年第5期980-983,共4页
International Eye Science
基金
深圳市科技计划项目(No.201103107)~~
关键词
人工晶状体
高度近视
散光
intraocular lens
high myopia
astigmatism
作者简介
杨浩江，硕士，副主任医师，研究方向：屈光手术、白内障。
通讯作者：司马晶，主任医师，研究方向：白内障、青光眼．yale75@hotmail．com
